← Back to Clinical Trials
Recruiting NCT07330622

NCT07330622 Polish Registry of Percutaneous Coronary Intervention for Chronic Total Occlusions

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07330622
Status Recruiting
Phase —
Sponsor National Institute of Cardiology, Warsaw, Poland
Condition Coronary Occlusion
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2025-05-21
Primary Completion 2026-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2025-05-21 with a primary completion date of 2026-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to evaluate the safety, efficacy, and clinical outcomes of percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) in patients treated in contemporary clinical practice in Poland. The main questions it aims to answer are: * What are the rates of procedural success and periprocedural complications of CTO PCI in routine clinical practice? * How do CTO PCI strategies and techniques, intravascular imaging, different treatment strategies, and mechanical circulatory support affect clinical outcomes? * How do clinical outcomes differ among different patient subgroups? * Can artificial intelligence-based analysis predict clinical and quality-of-life outcomes after CTO PCI? Patients undergoing CTO PCI as part of their standard medical care will be prospectively enrolled in a national, multicenter registry, with clinical, procedural, and follow-up data collected to evaluate real-world outcomes.

Eligibility Criteria

Inclusion Criteria: * Patients undergoing CTO PCI based on clinical grounds Exclusion Criteria: * Age \<18 years * Patient's refusal to participate in the registry

Contact & Investigator

Central Contact

Maksymilian Opolski, MD, PhD

✉ mopolski@ikard.pl

📞 0048223434127

Frequently Asked Questions

Who can join the NCT07330622 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Occlusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07330622 currently recruiting?

Yes, NCT07330622 is actively recruiting participants. Contact the research team at mopolski@ikard.pl for enrollment information.

Where is the NCT07330622 trial being conducted?

This trial is being conducted at Bialystok, Poland, Grodzisk Mazowiecki, Poland, Inowrocław, Poland, Katowice, Poland and 11 additional locations.

Who is sponsoring the NCT07330622 clinical trial?

NCT07330622 is sponsored by National Institute of Cardiology, Warsaw, Poland. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology